Cover Image

Virus-like antigen display for cancer vaccine development, what is the potential?

Saved in:

Bibliographic Details
Main Authors:	Adam F. Sander (Author), Pier-Luigi Lollini (Author)
Format:	Book
Published:	Taylor & Francis Group, 2018-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Virus-like particle vaccine displaying an external, membrane adjacent MUC16 epitope elicits ovarian cancer-reactive antibodies
by: Hsin-Fang Tu, et al.
Published: (2024)

Monitoring antigenic variations of enterovirus 71: implications for virus surveillance and vaccine development.
by: Min-Yuan Chia, et al.
Published: (2014)

Use of poxvirus display to select antibodies specific for complex membrane antigens
by: Ernest S. Smith, et al.
Published: (2023)

Phage display as a tool for vaccine and immunotherapy development
by: Krystina L. Hess, et al.
Published: (2020)

Development of a Novel Human Single Chain Antibody Against EGFRVIII Antigen by Phage Display Technology
by: Leila Rahbarnia, et al.
Published: (2016)

Antigenic differences between wildtype measles viruses and vaccine viruses in Indonesia
by: Made Setiawan, et al.
Published: (2016)

Overview of Plant-Derived Vaccine Antigens: Dengue Virus
by: Ravindra B Malabadi, et al.
Published: (2011)

Freeze-Drying of a Capsid Virus-like Particle-Based Platform Allows Stable Storage of Vaccines at Ambient Temperature
by: Kara-Lee Aves, et al.
Published: (2022)

Virus-Like Particle Vaccines
Published: (2020)

CARbodies: Human Antibodies Against Cell Surface Tumor Antigens Selected From Repertoires Displayed on T Cell Chimeric Antigen Receptors
by: Vanesa Alonso-Camino, et al.
Published: (2013)

Differences of antigenic profiles on immunoblotting of wild type measles virus and vaccine virus in Indonesia
by: Made Setiawan, et al.
Published: (2016)

Tumor antigens and vaccines in colorectal cancer
by: Zhongen Wu, et al.
Published: (2022)

Unlocking cancer vaccine potential: What are the key factors?
by: Michael Grant, et al.
Published: (2024)

Development of synthetic antigen vaccines for COVID-19
by: Maria da Conceição Viana Invenção, et al.
Published: (2021)

Antigenicity and diagnostic potential of vaccine candidates in human Chagas disease.
by: Shivali Gupta, et al.
Published: (2013)

Virus-like particle vaccines: immunology and formulation for clinical translation
by: Braeden Donaldson, et al.
Published: (2018)

Paediatric Primary Pachymeningeal Xanthogranuloma with Scattered Foci Displaying Reticulohistiocytoma-like Features
by: Miguel Fdo. Salazar, et al.
Published: (2015)

Zika virus-like particle (VLP) based vaccine.
by: Hélène Boigard, et al.
Published: (2017)

Novel tumour antigens and the development of optimal vaccine design
by: Victoria A Brentville, et al.
Published: (2018)

The 5th virus-like particle and nano-particle vaccines (VLPNPV) conference
by: Paul Engeroff, et al.
Published: (2019)

Anti-Fn14 Antibody-Conjugated Nanoparticles Display Membrane TWEAK-Like Agonism
by: Ahmed Aido, et al.
Published: (2021)

P18 surface antigen mediates reactivation of cerebral toxoplasmosis in murine models displaying an interferon-gamma immune response
by: Maguy Hamie, et al.
Published: (2020)

Therapeutic Cancer Vaccines-Antigen Discovery and Adjuvant Delivery Platforms
by: Neftali Ortega Alarcon, et al.
Published: (2022)

Next generation designer virus-like particle vaccines for dengue
by: Rahul Shukla, et al.
Published: (2019)

220 mutation in the hemagglutinin of avian influenza A (H7N9) virus alters antigenicity during vaccine strain development
by: Liqi Liu, et al.
Published: (2018)

Rabies virus glycoprotein variants display different patterns in rabies monosynaptic tracing
by: Takuma eMori, et al.
Published: (2014)

Vaccination with a chikungunya virus-like particle vaccine exacerbates disease in aged mice.
by: Maria T Arévalo, et al.
Published: (2019)

Biomimetic virus-like mesoporous silica nanoparticles improved cellular internalization for co-delivery of antigen and agonist to enhance Tumor immunotherapy
by: Yuan Gao, et al.
Published: (2023)

Substitute foods are more likely than their traditional food counterparts to display front-of-package references
by: Anthea Christoforou, et al.
Published: (2018)

Effective chikungunya virus-like particle vaccine produced in insect cells.
by: Stefan W Metz, et al.
Published: (2013)

Expression and Characterization of Yeast Derived Chikungunya Virus Like Particles (CHIK-VLPs) and Its Evaluation as a Potential Vaccine Candidate.
by: Shweta Saraswat, et al.
Published: (2016)

Development and characterization of an enterovirus 71 (EV71) virus-like particles (VLPs) vaccine produced in Pichia pastoris
by: Zhijian Yang, et al.
Published: (2020)

A recombinant Mycobacterium smegmatis-based surface display system for developing the T cell-based COVID-19 vaccine
by: Ziyu Wen, et al.
Published: (2023)

Development of a Lateral Flow Assay for the Detection of the Hepatitis C Virus Core Antigen
by: Erick Joan Vidal-Alcántara, et al.
Published: (2024)

Synthesis of Nitrostyrylthiazolidine-2,4-dione Derivatives Displaying Antileishmanial Potential
by: Omar Khoumeri, et al.
Published: (2024)

Development of Recombinant Antibody by Yeast Surface Display Technology
by: Mujahed I. Mustafa, et al.
Published: (2024)

Effects of aluminum-salt, CpG and emulsion adjuvants on the stability and immunogenicity of a virus-like particle displaying the SARS-CoV-2 receptor-binding domain (RBD)
by: Ozan S. Kumru, et al.
Published: (2023)

Generation of a Novel Bacteriophage Library Displaying scFv Antibody Fragments from the Natural Buffalo Host to Identify Antigens from Adult Schistosoma japonicum for Diagnostic Development.
by: Christopher G Hosking, et al.
Published: (2015)

Influenza B virus neuraminidase: a potential target for next-generation vaccines?
by: Thi Hoai Thu Do, et al.
Published: (2024)

The potential of currently unavailable herpes virus vaccines
by: Július Rajčáni, et al.
Published: (2018)